Low-Density Lipoprotein Cholesterol Increases Significantly During Brief Discontinuation of Atorvastatin and Correlates With Metabolite Half-Lives低密度脂蛋白胆固醇在阿托伐他汀短暂停药期间显著升高，并与代谢物半衰期相关PHARMACOLOGY RESEARCH & PERSPECTIVESIF2.32025-03-260OAAI
Mevalonate in blood and muscle: Response to atorvastatin treatment and the relationship to statin intolerance in patients with coronary heart diseaseCTS-CLINICAL AND TRANSLATIONAL SCIENCEIF2.82024-10-230OA
The potential for therapeutic drug monitoring of belatacept and other biologicals in solid organ transplantationBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32024-07-261OA
Validation of a novel direct method to determine reduced adherence to atorvastatin therapyEUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPYIF6.12024-01-091PRE
Clinical performance of volumetric finger-prick sampling for the monitoring of tacrolimus, creatinine and haemoglobin in kidney transplant recipientsBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32023-09-0411OA
Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin-Associated Muscle SymptomsCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52023-02-066OAAI
Fast and reliable quantification of busulfan in blood plasma using two-channel liquid chromatography tandem mass spectrometry: Validation of assay performance in the presence of drug formulation excipientsJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12021-09-019OAAI
Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant RecipientsCTS-CLINICAL AND TRANSLATIONAL SCIENCEIF2.82020-07-1111OAAI
Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trialEUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPYIF6.12020-07-0120OAAI
Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantationBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32020-02-165OAAI
Measured GFR by Utilizing Population Pharmacokinetic Methods to Determine Iohexol ClearanceKIDNEY INTERNATIONAL REPORTSIF5.72020-02-0119OAAI
A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart diseaseBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32019-11-0312OAAI
Effects of marine n-3 fatty acid supplementation in renal transplantation: A randomized controlled trialAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22019-03-0119OAAI
NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantationBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32017-08-1629OAAI
Costimulation Blockade: America First, Canada Second ... What About Norway?AMERICAN JOURNAL OF TRANSPLANTATIONIF8.22017-08-010OAAI
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal TransplantationTRANSPLANTATIONIF52017-08-0142OAAI
Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'BRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32017-04-030OAAI
The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantationBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32017-02-2717OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向